earn season final wind publish revis
model updat forecast nh onvo also
made minor adjust ghdx model
follow recent file
becton dickinson buy anoth solid quarter top bottom line
strength drove beat continu see bd core large-cap defens hold
abil drive organ growth mid-teen ep compound-annual-growth-rate
nanthealth nh buy cut ep forecast
respect revis model factor gps-relat
revenu pt move impli
revenu line hcit comp
orasur hold deliv solid beat second straight q/q
revenu declin dnag molecular collect system unit somewhat surpris
continu like leverag consum genom market believ
market still earli inning particularli asia greater confid
trajectori segment key stock work view
organovo onvo buy cut revenu forecast account
shortfal rel minor chang out-year estim onvo shift
focu bio-print platform technolog toward therapeut applic
hold one item call file disclos execut
usd/eur interest rate cross-curr swap juli expect reduc net interest
expens annual next three year translat ep benefit
ghdx major chang ep forecast follow recent
becton dickinson co
pleas see analyst certif import disclosur inform inform regard statu non-u analyst page report
histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product incom expens dividend share share analysisgross research sg ebitda oper incom net growth analysisnet incom healthcar
ghdx histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product expens share share ebitda analysisgross analysisnet healthcar
histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product amortz incom expens share share dilut dilut analysi non-gaap gross research sg ebitda depreci amortz oper incom net growth analysisnet incom dilut healthcar
histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product administr expens share share ep analysiscorpor gross gross administr analysisnet administr healthcar
onvo histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product expens share share analysiscorpor gross gross analysisnet healthcar
nh histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor total cancer cancer dev good expens expens incom equiti method share share ep ep non- excl ebitda analysi hcit gross margin research sg adjust ebitda oper net analysisnet research sg oper healthcar
histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product incom expens share share analysisgross sg oper margin incom incom net growth analysisnet incom healthcar
histor project quarterli incom statement
million except per share data
page
pleas see import disclosur inform page report
histor net product expens share share analysisgross sg oper incom incom net growth analysisnet healthcar
becton dickinson co
becton dickinson co global medic technolog compani manufactur sell broad rang medic suppli devic
laboratori equip diagnost product compani oper two busi divis medic life scienc diagnost
lead develop manufactur divers line oral fluid diagnost product specimen collect
devic use variou in-vitro diagnost test applic ivd product focus convert tradit diagnost
modal central test locat hospit clinic lab rapid point-of-car set physician offic home
subsidiari dna genotek focus provid high-qual biolog sampl collect product end-to-end servic human
genom microbiom infecti diseas applic oragene-dx oracollect-dx product line first fda
clear saliva-bas dna collect devic in-vitro diagnost use
nanthealth next-gener evidence-bas person healthcar compani focus enabl improv patient outcom
effect treatment decis critic ill nanthealth systems-bas approach integr novel diagnost large-scal
biometr phenotyp data track patient outcom deliv precis medicin adapt learn system clinic continu
improv decision-mak optim clinic pathway decis algorithm time nanthealth novel cancer test
enabl diagnosi molecular level measur whole genom proteom patient predict response/resist variou
organovo hold focus develop commerci function human tissu employ drug discoveri
develop biolog research therapeut implant treatment damag degener tissu organ
genom health ghdx develop market genomic-bas clinic diagnost test cancer offer servic clia-
accredit clinic refer laboratori locat california
develop manufactur sell product detect presenc certain biochem protein nucleic acid sampl
base proprietari xmap technolog xmap technolog enabl research laboratori biomed research field
perform bioassay identifi new gene discov develop new drug diagnos genet pathogen-rel diseas monitor
guid patient treatment
water lead supplier analyt instrument consum servic pharmaceut life scienc biochem industri
academ govern organ conduct research qa/qc activ
thermo fisher scientif lead provid analyt instrument equip consum softwar servic life scienc
healthcar industri environment safeti industri oper four busi divis life scienc solut analyt
instrument specialti diagnost laboratori product servic
becton dickinson co
pt reflect horizon dcf impli ev ebitda ep risk util new product uptak
pt base sotp model impli ev rev risk slower consum genom demand ou hiv self-test ramp
pt repres horizon dcf impli equiti valu rev line w/ hcit peer risk
reimburs uptak regulatori abil achiev self-fund statu
pt impli equiti valu rev discount back risk slower new product uptak order
delay pipelin develop abil scale profit
page
pleas see import disclosur inform page report
